Page last updated: 2024-08-21

durapatite and Benign Mastocytoma

durapatite has been researched along with Benign Mastocytoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Marycz, K; Serwotka-Suszczak, A; Sobierajska, P; Szymanski, D; Targonska, S; Wiglusz, RJ	1

Other Studies

1 other study(ies) available for durapatite and Benign Mastocytoma

Article	Year
Synergistic Effect of Toceranib and Nanohydroxyapatite as a Drug Delivery Platform-Physicochemical Properties and In Vitro Studies on Mastocytoma Cells. International journal of molecular sciences, 2022, Feb-09, Volume: 23, Issue:4 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dog Diseases; Dogs; Drug Carriers; Drug Delivery Systems; Drug Synergism; Durapatite; Indoles; Mastocytoma; Nanoparticles; Protein Kinase Inhibitors; Pyrroles	2022

Article

Year

Synergistic Effect of Toceranib and Nanohydroxyapatite as a Drug Delivery Platform-Physicochemical Properties and In Vitro Studies on Mastocytoma Cells.

International journal of molecular sciences, 2022, Feb-09, Volume: 23, Issue:4

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dog Diseases; Dogs; Drug Carriers; Drug Delivery Systems; Drug Synergism; Durapatite; Indoles; Mastocytoma; Nanoparticles; Protein Kinase Inhibitors; Pyrroles

2022